"Phase I clinical trials often last several months to a year. They usually have only 10 to 30 people. Doctors offer treatment in phase I clinical trials to people whose cancers won’t respond to standard treatments. Doctors don’t design these trials to test how well a treatment or combination of treatments works. However, the treatment given during this phase sometimes may help to slow or stop the growth of a person’s cancer."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.